Stocks · Health care · Electromedical & Electrotherapeutic Apparatus

Hyperfine, Inc.

HYPR Clue Score60
United States Fiscal year ends December CIK 0001833769 Results filed 8 Oct 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Maria Sainz
14 Dec 2022
President and CEO
Buy
5,000
$0.95
$4.75K
Jonathan M Rothberg
30 Nov 2022
Director
Buy
229,215
$0.82
$187.96K
Jonathan M Rothberg
29 Nov 2022
Director
Buy
47,007
$0.72
$33.85K
Jonathan M Rothberg
15 Nov 2022
Director
Buy
31,139
$0.92
$28.65K
Jonathan M Rothberg
14 Nov 2022
Director
Buy
34,488
$0.89
$30.69K
Jonathan M Rothberg
16 Aug 2022
Director
Buy
64,213
$1.48
$95.16K
Jonathan M Rothberg
12 Aug 2022
Director
Buy
303,137
$1.46
$441.67K
Jonathan M Rothberg
14 Jun 2022
Director
Buy
52,848
$2.26
$119.44K
HC Sponsor LLC
3 Feb 2022
10% owner
Buy indirect
21,947
$4.00
$87.79K
HC Sponsor LLC
26 Jan 2022
10% owner
Buy indirect
78,053
$3.75
$292.46K
HC Sponsor LLC
21 Jan 2022
10% owner
Buy indirect
25,000
$4.50
$112.55K
HC Sponsor LLC
12 Jan 2022
10% owner
Buy indirect
8,410
$6.57
$55.25K
HC Sponsor LLC
11 Jan 2022
10% owner
Buy indirect
2,913
$6.73
$19.60K
HC Sponsor LLC
10 Jan 2022
10% owner
Buy indirect
13,677
$6.70
$91.61K
HC Sponsor LLC
29 Dec 2021
10% owner
Buy indirect
100,000
$7.00
$700.00K

What was left out

Form 4 filings counted 107
Amendments (4/A) skipped 11
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 29
Transactions with no price 0
Shares from compensation/vesting 31,736,197
Sales filed before the plan box existed 10
History held since 23 Dec 2021